Build your LCADC preparation around the assessment-to-intervention chain. Screening tools detect possible substance use disorders, comprehensive assessment organizes biopsychosocial data, DSM-5 diagnosis draws conclusions, and level-of-care and treatment planning decisions act on those conclusions. Practice with vignettes where you classify each piece of information, compare competing clinical decisions, and check yourself against a rubric rather than memorizing isolated facts.
Screening, Assessment, and Diagnosis Are Three Different Tasks
Screening briefly detects possible problems; assessment comprehensively organizes biopsychosocial data; diagnosis is a formal conclusion from DSM-5 criteria. Because one vignette can supply facts for several purposes at once, identify which task the stem asks about before evaluating the answer choices.
Screening uses brief instruments such as the AUDIT, the DAST, or single-item screens to flag clients who need further evaluation; it never produces a diagnosis. Comprehensive assessment then gathers use history, medical and psychiatric status, family and social context, legal and occupational consequences, and prior treatment episodes, often combining structured interviews, collateral information, and standardized measures. Diagnosis applies the DSM-5 substance use disorder criteria across eleven criterion domains, with severity graded by the number of criteria met: two to three as mild, four to five as moderate, and six or more as severe, plus remission specifiers.
The concepts overlap at exactly one point: a completed screen looks like the start of a diagnosis, and a completed assessment looks like permission to treat. Practice keeping the tasks in order. If a stem ends with a positive screen, the next-step answer is typically a thorough assessment rather than a diagnosis or a treatment plan; if a stem supplies a completed assessment, the diagnostic conclusion and severity rating come next. Train yourself to read the last sentence of the vignette first, name the task it requests, then evaluate each option against that task.
| Task | Purpose | Typical instruments or outputs | What a sound answer does |
|---|---|---|---|
| Screening | Rapidly detect possible substance use disorder | AUDIT, DAST, brief single-item screens | Recommend further assessment or a brief intervention |
| Assessment | Organize biopsychosocial and functional data | Comprehensive interview, collateral input, standardized measures | Weigh history, patterns, and consequences before concluding |
| Diagnosis | Formal clinical conclusion | DSM-5 criteria with severity and remission specifiers | Count criteria across domains and state severity |
| Treatment planning | Convert conclusions into action | Goals, measurable objectives, specific interventions | Match interventions to readiness, culture, and level of care |
Scenario: Substance-Induced or Independent Depressive Disorder?
Co-occurring condition questions turn on chronology and substance specificity. Depressive symptoms during heavy use suggest a substance-induced process until a sustained abstinence period shows the symptoms persist independently.
Scenario: a 34-year-old reports three years of daily heavy alcohol use, recent job loss, low mood, insomnia, and poor concentration, and scores high on a depression screen. The tempting mistake is recording a major depressive disorder diagnosis at intake and building the entire plan around it. That conclusion outruns the data, because every presenting symptom also fits an alcohol-induced mood disturbance, and an incorrect diagnosis can drive unnecessary medication referrals, the wrong level of care, and a plan the client cannot yet engage with.
The better decision is to document the timeline: symptoms during active use, their course relative to drinking episodes, any prior depressive episodes during sustained abstinence, and suicide risk requiring immediate attention regardless of cause. Write the mood concern as provisional and reassess after a defined abstinence or reduction period, per the DSM-5 distinction between substance-induced and independent disorders. This matters because the differential changes the plan: withdrawal management and reassessment first, versus an integrated dual-diagnosis plan, versus referral for psychiatric evaluation. Practice writing the timeline before you write any diagnosis.
Level-of-Care Logic Is Dimensional, Not Severity-Only
The ASAM Criteria assess six dimensions, and treatment intensity follows the highest-risk dimension rather than use severity alone. Practice mapping each vignette fact to a dimension before judging intensity.
The six ASAM dimensions cover, in order: acute intoxication and withdrawal risk; biomedical conditions; emotional, behavioral, and cognitive conditions; readiness to change; relapse or continued use potential; and the recovery environment. A client can show severe use but low withdrawal risk and high readiness, or moderate use but a home environment saturated with active use and easy access. The dimensional structure exists precisely so that a single number, such as days or quantity used, does not decide placement by itself.
Scenario two: a client with opioid use disorder is medically stable, has no significant psychiatric history, and expresses ambivalence about treatment, but lives with two family members in active opioid use. The plausible mistake is recommending the least intensive setting because the biomedical and emotional dimensions look clean. The better decision weighs dimensions five and six: high relapse risk and an unsupportive environment can justify a more structured level of care or, at minimum, a plan that addresses housing and recovery supports before relying on motivation alone. On practice items, check every dimension for facts before you let the most obvious one dictate the answer.
Treatment Planning: Goals, Objectives, and Matching the Stage of Change
Keep three planning layers distinct: broad goals, measurable time-bound objectives, and specific interventions. Then match the intervention style to the client's stage of change instead of applying one method to everyone.
A goal states direction, such as achieving sustained recovery from alcohol use. An objective makes it measurable: attend three support meetings weekly for the next 60 days, verified by attendance records. An intervention names the method the counselor will use, such as motivational interviewing, cognitive-behavioral relapse-prevention work, or a referral. When you review any practice plan, ask what is missing or weakest; the flaw to look for is an objective with no measurable behavior or timeframe, or an intervention disconnected from the stated goal.
Stage-of-change matching is the second skill. For a precontemplative client, the better decision is reflective listening, exploring ambivalence, and developing discrepancy in the motivational interviewing style, not handing over a relapse-prevention workbook designed for someone already in action. The plausible mistake in vignettes is an eager plan full of action-oriented tasks offered to a client who has not yet voiced any intent to change, which predicts disengagement. Check whether the vignette's quoted speech signals contemplation, preparation, or action, and let that signal select the intervention.
Psychopharmacology: Match Medication Mechanism to Disorder and State
Learn the agonist, partial agonist, and antagonist logic for opioid medications and the main alcohol pharmacotherapies. Prioritize mechanism, rationale, contraindications, and the counselor's supporting role over prescribing detail.
For opioid use disorder, place each medication by mechanism: methadone is a full opioid agonist; buprenorphine is a partial agonist with a ceiling effect that lowers overdose risk; naltrexone is an antagonist that blocks opioid effects but requires the client to be fully detoxed first, because administering it to a person with opioids on board produces precipitated withdrawal. If a vignette mentions recent opioid use and a proposed antagonist, the detail to catch is that contraindication and the need for medical evaluation before initiation.
For alcohol use disorder, connect each agent to its rationale: naltrexone reduces the rewarding effects of alcohol, acamprosate supports abstinence by easing protracted withdrawal-related discomfort, and disulfiram deters drinking through an aversive reaction when alcohol is consumed. Also learn interactions and contraindications at the level of mechanism. Finally, keep scope clear: counselors do not prescribe or adjust medication. The counselor's role is psychoeducation, adherence support, monitoring observed changes, and coordinating with the prescriber, so in practice items prefer answers that describe collaboration over answers that describe a counselor making a medication decision.
Confidentiality: Federal SUD Rules Add Stricter Consent Than HIPAA
HIPAA sets the general privacy floor, while 42 CFR Part 2 imposes stricter consent and redisclosure limits on records from federally assisted substance use disorder programs. Both can apply to the same record at once.
Part 2 requires a specific written consent that names the information disclosed, the recipient, and the purpose, and it restricts redisclosure by recipients far more tightly than general health privacy rules. It also supports segmenting substance use treatment records from the broader medical record. Certain disclosures are permitted without consent under defined conditions, including medical emergencies and court orders meeting specific standards, so distinguish a consent exception from a general permission when evaluating options.
Ethics scenarios layer on top: mandated reporting of suspected child abuse or neglect, imminent-danger exceptions, and duty-to-protect situations follow their own legal rules and can override confidentiality within narrow limits. When a vignette asks for the best action, separate the two questions: is a specific exception actually met here, and what is the least disclosure that satisfies it. Documenting the decision and consulting a supervisor when the situation is ambiguous is usually part of the better answer, because professional responsibility includes knowing the limits of your own certainty.
A Four-Week Practice Sequence and Self-Check Rubric
Sequence your review: criteria and screening first, differential and timeline drills second, level-of-care and planning third, ethics and pharmacology mixed sets last. Grade every practice vignette against a rubric, not just a score.
Week one, master the eleven DSM-5 criterion domains, severity thresholds, and two or three screening instruments, including what each screens for. Week two, run timeline drills: for each vignette, write whether symptoms occur during use, during withdrawal, or after sustained abstinence, and label the diagnosis provisional or independent. Week three, map vignette facts onto the six ASAM dimensions and draft a goal, a measurable objective, and a stage-matched intervention. Week four, mix ethics, confidentiality, and pharmacology items so you practice switching between task types within a single session.
Practical exercise: take any practice vignette and produce four outputs in twenty minutes: a list of screening findings, an assessment summary organized by domain, a provisional diagnostic statement with the timeline evidence, and a three-part plan. Then score it against this rubric: every fact is classified under the correct task; the diagnostic statement names its evidence; at least five of the six ASAM dimensions are addressed with facts; the objective is measurable and time-bound; the intervention matches the quoted stage of change; and any confidentiality decision names the specific exception relied on. Expected observations on your first attempts include unmeasurable objectives and premature diagnostic conclusions; both are rubric flags to rework, not reasons to change strategy.
- Readiness check one: you can list the eleven DSM-5 criterion domains and the severity thresholds from memory.
- Readiness check two: given any vignette, you can name all six ASAM dimensions and attach at least one fact to each.
- Readiness check three: you can explain agonist, partial agonist, and antagonist in one sentence each and state the precipitated withdrawal condition.
- Readiness check four: you can state how Part 2 consent differs from general health privacy consent without looking.
- Readiness check five: your last five practice plans each contain a measurable objective and a stage-matched intervention.
References and further reading
Use these references to explore the concepts and check the latest information from the relevant organizations.